Icahn School of Medicine at Mount Sinai Grants Exclusive License to...

Under the new agreement, CDI now can make use of, distribute, sublicense and sell cellular products that employ the licensed technology for therapeutic use.

http://www.prweb.com/releases/2013/5/prweb10766486.htm